Advances in genetic research may improve the prevention, diagnosis, and treatment of women’s cancers. “More genes are being found and fewer families are having to wonder if there is something genetic that may increase their risk, or future generations’ risk, of developing cancer,” says Judy Garber, MD, MPH, director of the Center for Cancer Genetics and Prevention at Dana-Farber and a leader in the Susan F. Smith Center for Women’s Cancers.
In this Cancer Conversations podcast episode, Garber discusses the latest in genetic research, including hereditary risks, genetic testing, and treatment options.
“One of the most exciting developments is the knowledge that patients with hereditary risk have tumors that are different biologically, and those tumors can be treated using drugs that we’ve never used before,” Garber adds.
The Cancer Conversations series features Q&A-style conversations with Dana-Farber physicians, clinicians, and researchers. Topics include breast cancer research, precision cancer medicine, integrative therapies, cancer genetics, and more. Visit the Cancer Conversations page for more episodes and the Dana-Farber podcast page for more cancer podcast series.